Use of parenteral nutrition in term and late preterm infants: an Australian and New Zealand survey. Issue 1 (14th July 2022)

• Record Type: Journal Article
• Authors: Moon, Kwi; Rao, Shripada; Patole, Sanjay; Simmer, Karen
• Is Part Of: British journal of nutrition. Volume 128:Issue 1(2022)
• Page Start: 131
• Page End: 138
• Publication Date: 2022-07-14
• Subjects: Parenteral nutrition -- Amino acids -- Lipids; Nutrition -- Periodicals; 572.4
• DOI: 10.1017/S0007114521003020
• Languages: English
• ISSNs: 0007-1145

Abstract

Abstract: There is limited information regarding the use of parenteral nutrition (PN) in term and late preterm infants. We conducted a survey to study the current clinical practices within Australia and New Zealand (ANZ). A fifteen-question online survey was distributed to 232 neonatologists and fifty-five paediatric intensivists across ANZ between September and November 2019. At least one neonatologist from twenty-seven out of thirty tertiary neonatal intensive care units responded (90 %). Responses were received from sixty-nine neonatologists (30 %) and seven paediatric intensivists (13 %). The overall response rate was 26 % (76/287). Thirty-three percent (25/76) commenced PN within 24 h of admission, 27 % (20/75) between 24 and 48 h, 24 % (18/75) between 48 and 72 h, 9 % (7/75) between 72 and 96 h and 4 % (3/75) between 96 h and 7 days. None of the respondents commenced PN after 7 d of admission. Sixty-one percent (46/75) aimed for 1·5–3 g/kg per d of parenteral amino acids, whereas 27 % (20/75) aimed for 2–3 g/kg per d. Renal failure (59 %; 38/64) and high plasma urea (44 %; 28/64) were the major indications for withholding/decreasing the amino acid intake. Eighty-three percent (63/76) aimed for a dose of 2·5g–3·5 g/kg per d of parenteral lipids; about 9 % (7/76) targeted a dose of 1–2·5 g/kg per d and 4 % (3/76) for > 3·5 g/kg per d. Thirty-two percent (24/74) reported that they would withhold/decrease the dose of parenteral lipids in infants with sepsis. The variations in clinicians' practices with respect to the use of PN in term and late preterm infants highlight the need for high-quality research in this population.